EC Number   |
Title |
Organism |
|---|
   1.14.99.20 | Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy a pilot study |
Homo sapiens |
| 1.14.99.20 | Bronsted analysis reveals Lys218 as the carboxylase active site base that deprotonates vitamin K hydroquinone to initiate vitamin K-dependent protein carboxylation |
Leptospira interrogans |
| 1.14.99.20 | Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat |
Rattus norvegicus |
| 1.14.99.20 | Developmental changes of vitamin K epoxidase and reductase activities involved in the vitamin K cycle in human liver |
Homo sapiens |
| 1.14.99.20 | Mutagenesis of vitamin K-dependent carboxylase demonstrates a carboxyl terminus-mediated interaction with vitamin K hydroquinone |
Bos taurus |
| 1.14.99.20 | Oxygen dependence of vitamin K-dependent carboxylase and vitamin K epoxidase |
Rattus norvegicus |
| 1.14.99.20 | Profactor IX propeptide and glutamate substrate binding sites on the vitamin K-dependent carboxylase identified by site-directed mutagenesis |
Bos taurus |
| 1.14.99.20 | Propeptide and glutamate-containing substrates bound to the vitamin K-dependent carboxylase convert its vitamin K epoxidase function from an inactive to an active state |
Bos taurus |
| 1.14.99.20 | The inhibition of vitamin K-dependent carboxylase by cyanide |
Bos taurus |
| 1.14.99.20 | The vitamin K-dependent carboxylase has been acquired by Leptospira pathogens and shows altered activity that suggests a role other than protein carboxylation |
Leptospira interrogans |
